Clinical Trial Update: Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating INCB019602 with Metformin in Type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• INCB019602 (INCB019602)
• metformin (metformin)

Snippet

Sponsor: Incyte Corporation | Conditions: Type 2 Diabetes | Phase 2 | Status: TERMINATED